Mackay Shields LLC’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Mackay Shields LLC’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-66,848	Closed	-$3.51M	–	1652
2020 Q3	$3.51M	Sell	66,848 -11,200	-14%	-$464K	0.02%	545
2020 Q2	$2.6M	Buy	78,048 +16,600	+27%	+$529K	0.02%	641
2020 Q1	$1.67M	Sell	61,448 -28,400	-32%	-$791K	0.02%	744
2019 Q4	$1.77M	Sell	89,848 -5,700	-6%	-$91.1K	0.01%	919
2019 Q3	$1.24M	Buy	95,548 +100	+0.1%	+$1.21K	0.01%	1066
2019 Q2	$1.19M	Buy	95,448 +64,717	+211%	+$859K	0.01%	1084
2019 Q1	$446K	Buy	30,731 +1,500	+5%	+$19.2K	﹤0.01%	1203
2018 Q4	$323K	Sell	29,231 -2,344	-7%	-$32.6K	﹤0.01%	1239
2018 Q3	$830K	Hold	31,575	–	–	0.01%	920
2018 Q2	$645K	Sell	31,575 -2,500	-7%	-$53.6K	﹤0.01%	1042
2018 Q1	$618K	Buy	+34,075	New	+$568K	﹤0.01%	1084

Mackay Shields LLC's MNTA Position: Q4 2020 in Review

Mackay Shields LLC sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 66,848 shares — an estimated $3.51M sold.

Mackay Shields LLC first reported a position in MNTA in Q1 2018 and held it in 11 quarters. The position peaked at $3.51M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Mackay Shields LLC reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Mackay Shields LLC sold 66,848 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $3.51M.
Mackay Shields LLC first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 11 quarters.
Mackay Shields LLC's Momenta Pharmaceuticals, Inc. position peaked at $3.51M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Mackay Shields LLC's 13F filing for Q4 2020, filed 16 Feb 2021.